Immunomodulatory effect of umbilical cord mesenchymal stem cells on type 2 diabetes mellitus
- VernacularTitle:脐带间充质干细胞对2型糖尿病的免疫调节作用
- Author:
Chunlan CHEN
1
;
Meiyi YE
;
Yuwei PAN
;
Jia YUAN
;
Pengjun ZHOU
Author Information
- Publication Type:Journal Article
- Keywords: umbilical cord mesenchymal stem cell; type 2 diabetes mellitus; immunity; insulin resistance; inflammation; macrophage
- From: Chinese Journal of Tissue Engineering Research 2025;29(23):5031-5040
- CountryChina
- Language:Chinese
- Abstract: BACKGROUND:Umbilical cord mesenchymal stem cells present immunomodulatory function and multidirectional differentiation potential.Umbilical cord mesenchymal stem cells can actively improve the chronic low-grade inflammation state in type 2 diabetes mellitus and which is important for preventing the development of type 2 diabetes mellitus progression.OBJECTIVE:To review the research progress of umbilical cord mesenchymal stem cells in the treatment of type 2 diabetes mellitus through immunomodulatory effect.METHODS:Using"umbilical cord mesenchymal stem cells,UC-MSCs,mesenchymal stem cells,MSCs,type 2 diabetes mellitus,T2DM,immunity,insulin resistance,inflammation"as Chinese and English search terms,articles were searched on CNKI,Web of Science and PubMed databases.Relevant reviews,research papers and theses were screened and 88 papers were collected for summarization based on the inclusion and exclusion criteria.RESULTS AND CONCLUSION:Umbilical cord mesenchymal stem cells can effectively delay the occurrence and development of type 2 diabetes mellitus by reducing inflammatory response,inducing macrophages to M2 polarization,increasing the sensitivity of target organs to insulin,improving insulin resistance,and alleviating the dysfunction of islet beta cells through immune regulation.However,before umbilical cord mesenchymal stem cell transplantation can become a routine treatment,large-scale basic and applied basic research is needed to determine the optimal treatment regimen and efficacy.
